Literature DB >> 19945533

A model of symptomatic infantile spasms syndrome.

Morris H Scantlebury1, Aristea S Galanopoulou, Lenka Chudomelova, Emmanuel Raffo, David Betancourth, Solomon L Moshé.   

Abstract

Infantile spasms are characterized by age-specific expression of epileptic spasms and hypsarrhythmia and often result in significant cognitive impairment. Other epilepsies or autism often ensue especially in symptomatic IS (SIS). Cortical or subcortical damage, including white matter, have been implicated in the pathogenesis of SIS. To generate a model of SIS, we recreated this pathology by injecting rats with lipopolysaccharide and doxorubicin intracerebrally at postnatal day (P) 3 and with p-chlorophenylalanine intraperitoneally at P5. Spasms occurred between P4 and 13 and were associated with ictal EEG correlates, interictal EEG abnormalities and neurodevelopmental decline. After P9 other seizures, deficits in learning and memory, and autistic-like behaviors (indifference to other rats, increased grooming) were observed. Adrenocorticotropic hormone (ACTH) did not affect spasms. Vigabatrin transiently suppressed spasms at P5. This new model of SIS will be useful to study the neurobiology and treatment of SIS, including those that are refractory to ACTH. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945533      PMCID: PMC2824012          DOI: 10.1016/j.nbd.2009.11.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  38 in total

1.  The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration.

Authors:  Zvonka Rener Primec; Janez Stare; David Neubauer
Journal:  Epilepsia       Date:  2006-12       Impact factor: 5.864

Review 2.  Developmental outcome with and without successful intervention.

Authors:  Rochelle Caplan; Prabha Siddarth; Gary Mathern; Harry Vinters; Susan Curtiss; Jennifer Levitt; Robert Asarnow; W Donald Shields
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 3.  Role of subcortical structures in the pathogenesis of infantile spasms: what are possible subcortical mediators?

Authors:  F A Lado; S L Moshé
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

Review 4.  How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis.

Authors:  K L Brunson; M Eghbal-Ahmadi; T Z Baram
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

Review 5.  West syndrome: long-term prognosis and social aspects.

Authors:  R E Appleton
Journal:  Brain Dev       Date:  2001-11       Impact factor: 1.961

6.  NMDA receptor antagonists impair motor performance in immature rats.

Authors:  A Mikulecká; P Mares
Journal:  Psychopharmacology (Berl)       Date:  2002-06-25       Impact factor: 4.530

7.  Precise characterization and quantification of infantile spasms.

Authors:  P Kellaway; R A Hrachovy; J D Frost; T Zion
Journal:  Ann Neurol       Date:  1979-09       Impact factor: 10.422

8.  A long-term follow-up study of 214 children with the syndrome of infantile spasms.

Authors:  R Riikonen
Journal:  Neuropediatrics       Date:  1982-02       Impact factor: 1.947

9.  A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment.

Authors:  Maureen G Price; Jong W Yoo; Daniel L Burgess; Fang Deng; Richard A Hrachovy; James D Frost; Jeffrey L Noebels
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

10.  Infantile spasms and Down syndrome: a new animal model.

Authors:  Miguel A Cortez; Liqing Shen; Ying Wu; Ilyas S Aleem; Catherine H Trepanier; Hamid R Sadeghnia; Asim Ashraf; Ashlin Kanawaty; Chen-Chu Liu; Lee Stewart; O Carter Snead
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

View more
  53 in total

1.  In search of epilepsy biomarkers in the immature brain: goals, challenges and strategies.

Authors:  Aristea S Galanopoulou; Solomon L Moshé
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

2.  A pulse rapamycin therapy for infantile spasms and associated cognitive decline.

Authors:  Emmanuel Raffo; Antonietta Coppola; Tomonori Ono; Stephen W Briggs; Aristea S Galanopoulou
Journal:  Neurobiol Dis       Date:  2011-04-12       Impact factor: 5.996

3.  Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms.

Authors:  Tomonori Ono; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Epilepsia       Date:  2011-07-19       Impact factor: 5.864

Review 4.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

Review 5.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 6.  The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Paola Lenzi; Alessandro Frati; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

7.  APC conditional knock-out mouse is a model of infantile spasms with elevated neuronal β-catenin levels, neonatal spasms, and chronic seizures.

Authors:  Antonella Pirone; Jonathan Alexander; Lauren A Lau; David Hampton; Andrew Zayachkivsky; Amy Yee; Audrey Yee; Michele H Jacob; Chris G Dulla
Journal:  Neurobiol Dis       Date:  2016-11-13       Impact factor: 5.996

8.  CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms.

Authors:  Stephen W Briggs; Wenzhu Mowrey; Charles B Hall; Aristea S Galanopoulou
Journal:  Epilepsia       Date:  2013-10-28       Impact factor: 5.864

Review 9.  Pathophysiology of epileptic encephalopathies.

Authors:  Fred A Lado; Guido Rubboli; Giuseppe Capovilla; Pippo Capovilla; Giuliano Avanzini; Solomon L Moshé
Journal:  Epilepsia       Date:  2013-11       Impact factor: 5.864

Review 10.  Basic mechanisms of catastrophic epilepsy -- overview from animal models.

Authors:  Aristea S Galanopoulou
Journal:  Brain Dev       Date:  2013-01-11       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.